This Article
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paiement, G. D.
Right arrow Articles by Harris, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paiement, G. D.
Right arrow Articles by Harris, W. H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?

The Journal of Bone and Joint Surgery, Vol 75, Issue 6 893-898, Copyright © 1993 by Journal of Bone and Joint Surgery, Inc


JOURNAL CONTENTS

Routine use of adjusted low-dose warfarin to prevent venous thromboembolism after total hip replacement

GD Paiement, SJ Wessinger, R Hughes and WH Harris
Massachusetts General Hospital and Harvard Medical School, Boston 02114.

The efficacy and safety of routine use of adjusted low-dose warfarin for twelve weeks--without sonography or venography--for the prophylaxis of deep-vein thrombosis after total hip replacement was assessed in 268 patients (134 men and 134 women) who were between the ages of forty and eighty-five years (average, sixty-one years). The patients were given warfarin orally both before and after the operation. The initial dose was usually ten milligrams on the night before the operation and five milligrams on the night after the operation. Thereafter, the dose was adjusted to keep the prothrombin time between fourteen and sixteen seconds. The control time was ten to twelve seconds. The partial thromboplastin time was also measured, and the dose of warfarin was reduced if the value was more than fifty seconds. All 268 patients continued to take low-dose warfarin for twelve weeks after the operation. There were 170 primary and ninety-eight revisional total hip-replacement operations. Thirty-four patients (13 per cent) had a history of thromboembolic disease or venous stasis in a lower limb. Neither phlebography nor sonography was done routinely. All of the patients were followed for six months after the operation. There were no fatal pulmonary emboli during the period of the study and no known pulmonary emboli after any patient was discharged from the hospital. Two non-fatal pulmonary emboli were identified, both during hospitalization. Ten patients (4 per cent) had an episode of major bleeding--a wound hematoma in nine and a gastrointestinal hemorrhage in one--during hospitalization.(ABSTRACT TRUNCATED AT 250 WORDS)
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JBJSHome page
S. Dhupar, R. Iorio, W. L. Healy, and K. Dhimitri
A Comparison of Discharge and Two-Week Duplex Ultrasound Screening Protocols for Deep Venous Thrombosis Detection Following Primary Total Joint Arthroplasty
J. Bone Joint Surg. Am., November 1, 2006; 88(11): 2380 - 2385.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
J. R. Lieberman and W. K. Hsu
Prevention of Venous Thromboembolic Disease After Total Hip and Knee Arthroplasty
J. Bone Joint Surg. Am., September 1, 2005; 87(9): 2097 - 2112.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
W. H. Geerts, G. F. Pineo, J. A. Heit, D. Bergqvist, M. R. Lassen, C. W. Colwell, and J. G. Ray
Prevention of Venous Thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Chest, September 1, 2004; 126(3_suppl): 338S - 400S.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
T. P. Sculco, C. W. Colwell Jr., V. D. Pellegrini Jr., G. H. Westrich, and F. Bottner
Prophylaxis Against Venous Thromboembolic Disease in Patients Having a Total Hip or Knee Arthroplasty
J. Bone Joint Surg. Am., March 1, 2002; 84(3): 466 - 477.
[Full Text]


Home page
ChestHome page
W. H. Geerts, J. A. Heit, G. P. Clagett, G. F. Pineo, C. W. Colwell, F. A. Anderson Jr., and H. B. Wheeler
Prevention of Venous Thromboembolism
Chest, January 1, 2001; 119(1_suppl): 132S - 175S.
[Full Text] [PDF]


Home page
JBJSHome page
E. A. SALVATI, V. D. PELLEGRINI, N. E. SHARROCK, P. A. LOTKE, D. W. MURRAY, H. POTTER, and G. H. WESTRICH
Symposium - Recent Advances in Venous Thromboembolic Prophylaxis During and After Total Hip Replacement
J. Bone Joint Surg. Am., February 1, 2000; 82(2): 252 - 70.
[Full Text]


Home page
VASC ENDOVASCULAR SURGHome page
D. J. Dixon, M. A. Ricci, J. G. Reid, C. Possidente, S. J. Incavo, and J. G. Howe
Is Impedance Plethysmography a Safe Test After Total Joint Replacement?
Vascular and Endovascular Surgery, May 1, 1998; 32(3): 255 - 260.
[Abstract] [PDF]


Home page
JBJSHome page
J. R. LIEBERMAN, J. WOLLAEGER, F. DOREY, B. J. THOMAS, D. J. KILGUS, M. J. GRECULA, G. A. FINERMAN, and H. C. AMSTUTZ
The Efficacy of Prophylaxis with Low-Dose Warfarin for Prevention of Pulmonary Embolism following Total Hip Arthroplasty
J. Bone Joint Surg. Am., March 1, 1997; 79(3): 319 - 25.
[Abstract] [Full Text]


Home page
JBJSHome page
D. Linville, R. J. Fragen, S. D. Stulberg, R. Wixson, S. Glisson, and E. Librojo
Correspondence
J. Bone Joint Surg. Am., June 1, 1996; 78(6): 967 - 8.
[Full Text]